CASB7439 constructs

Details for Australian Patent Application No. 2010252012 (hide)

Owner GlaxoSmithKline Biologicals s.a.

Inventors Blais, Normand; Harvey, Martine; Pilorget, Anthony; Rioux, Clement

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010252012

PCT Pub. Number WO2010/136443

Priority 61/181,380 27.05.09 US; 61/220,396 25.06.09 US

Filing date 25 May 2010

Wipo publication date 2 December 2010

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 December 2011 PCT application entered the National Phase

  PCT publication WO2010/136443 Priority application(s): WO2010/136443

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010252013-Offshore structure and mooring arrangement

2010252007-(Dihydro) imidazoiso [5, 1-a] quinolines as FSH receptor agonists for the treatment of fertility disorders